Navigation Links
Research pioneer in the developmental origins of psychiatric illness is awarded the Sackler prize
Date:1/18/2008

A leader in recent research on the interaction of genes and environment in the development of psychiatric illness, Avshalom Caspi, Ph.D. of King's College London, has been awarded the Mortimer D. Sackler, M.D., Prize for Distinguished Achievement in Developmental Psychobiology. Presented jointly by the Sackler Institute for Development Psychobiology at Columbia University Medical Center and the Sackler Institute for Developmental Psychobiology at Weill Cornell Medical College, the $60,000 award honors the 90th birthday of Dr. Sackler, and was established through gifts by his seven children.

The award was announced on Dec. 7 at the Sackler Institute for Development Psychobiology at Columbia University Medical Center. On April 25, 2008, Dr. Caspi will give grand rounds in psychiatry at the New York State Psychiatric Institute at Columbia University Medical Center, and on April 30, he will give grand rounds at NewYork-Presbyterian/Weill Cornell. During his visit to New York City he will meet with physicians/scientists at both institutes.

Dr. Caspi's work has combined new knowledge of commonly occurring gene variants linked to psychiatric illnesses, such as major depression, with careful longitudinal studies that have provided quantitative measures of specific early stressors, such as child abuse. The results have delineated the interactions of specific gene variants with certain defined early environments to explain a significant portion of the previously baffling variance between individuals in their vulnerabilities to psychiatric illness.

"This work, at last, gives us the basis for studying the mechanisms of gene-environment interaction itself, instead of simply using the phrase as a metaphor for the complexities of development," says Myron Hofer, director of the Columbia Sackler Institute.

"Dr. Caspi's work underscores the importance of the developmental perspective and how the mature being is greatly influenced by experiences during development in combination with biological/genetic predispositions," adds Dr. B.J. Casey, the Sackler Professor of Psychiatry and director of the Sackler Institute for Developmental Psychobiology at Weill Cornell Medical College.

Avshalom Caspi, Ph.D.

Dr. Avshalom Caspi is professor in the Social, Genetic and Developmental Psychiatry Research Centre at King's College London and the Institute of Psychiatry at Maudsley Hospital. A graduate of the University of California, Santa Cruz, Dr. Caspi earned his master of arts degree and doctorate in developmental psychology from Cornell University. He taught at Harvard before joining the University of Wisconsin faculty in 1989 and began his present appointment with the Institute of Psychiatry at King's College London in 1997.


'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

Related biology news :

1. Research shows skeleton to be endocrine organ
2. Newly created cancer stem cells could aid breast cancer research
3. Dominant cholesterol-metabolism ideas challenged by new research
4. Researchers identify proteins involved in new neurodegenerative syndrome
5. Texas researchers and educators head for Antarctica
6. MGH researchers describe new way to identify, evolve novel enzymes
7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
11. Story ideas from the Journal of Lipid Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)...   Strategic Cyber Ventures , the industry,s first ... $3.5 million investment in  Polarity , the first commercial ... DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran and ... series A round of funding. This new funding will ...
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
Breaking Biology News(10 mins):
(Date:2/28/2017)... Massachusetts and NEW YORK , ... Biologics License Application accepted by the FDA for avelumab  ... the disease has metastasized   ... Germany , in the US and ... the US Food and Drug Administration (FDA) has accepted for ...
(Date:2/27/2017)... 2017 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... Food and Drug Administration (FDA) has accepted the ... for DSUVIA™ (formerly ARX-04) (sufentanil sublingual tablet, 30 ... acute pain in a medically supervised setting. The ...
(Date:2/27/2017)... ... ... The Catalyst Midwest premix manufacturing facility has been certified as ... private label organic services. , The first organic product is Organic 18 Percent Layer ... Dynamite Marketing, which owns the facility. , Catalyst already has received the Safe ...
(Date:2/24/2017)... ... February 24, 2017 , ... Chef Jodi Abel has returned from her ... several cities, she gained a number of delicious recipes and new techniques to share ... South Africa’s Western Cape province. It is internationally renowned for its incredible wine ...
Breaking Biology Technology: